Skip to content
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
Yesterday, Sen. Bernie Sanders held a meeting about the new class of groundbreaking diabetes and weight-loss medicines. Next week, he will hold a hearing […]
The Senate Finance Committee will hold a hearing tomorrow on “understanding the benefits of the Inflation Reduction Act.” Expect to hear a lot of rhetoric
Four key facts ahead of tomorrow’s drug pricing hearing Read More »
Voters want to bolster American manufacturing across biopharmaceutical and biotechnology sectors, according to a new public opinion survey conducted by Morning Consult for the
New survey checks pulse on voters’ concerns for innovation and biomanufacturing Read More »
“The world of biotechnology is in the midst of a wave of exciting research and clinical advances—from artificial intelligence-based drug discovery to cell and
GEN State of Biotechnology 2024: John F. Crowley on driving biotech forward Read More »
The announcement of “maximum fair prices” for the first 10 medicines targeted under the Inflation Reduction Act (IRA) has renewed questions and concerns about
The economics of the Inflation Reduction Act’s impact on innovation Read More »
Drug price controls in the Inflation Reduction Act (IRA) involve unconstitutional coercion and will destroy innovation in transformational treatments that save patients’ lives, the
BIO files amicus brief challenging IRA drug price controls Read More »
The Inflation Reduction Act (IRA) has already begun to shift the way that innovative companies are investing in future breakthroughs. Over the past few
In recognition of significant advancements in biotechnology’s impact on our food supply, the Biotechnology Innovation Organization (BIO) recently recognized industry leaders who helped drive
BIO honors innovators with 2024 Leadership in Agri-Biotechnology Awards Read More »
John F. Crowley, President & CEO of the Biotechnology Innovation Organization (BIO), highlighted the crucial themes of “innovation, access, and advocacy” during his keynote
In implementing the Inflation Reduction Act (IRA), the Centers for Medicare and Medicaid Services (CMS) has made efforts to unnecessarily broaden the law with
CMS overreach will impede innovation Read More »
